Amikura K, Kobari M, Matsuno S
First Department of Surgery, Tohoku University School of Medicine, Sendai, Japan.
Int J Pancreatol. 1995 Apr;17(2):139-46. doi: 10.1007/BF02788531.
By measuring the doubling time of liver metastasis, the authors investigated the possibility of occult liver metastasis at the time of pancreatectomy in patients with pancreatic carcinoma. We calculated tumor doubling times of liver metastases in six patients after pancreatectomy for periampullary carcinoma and compared with cell doubling times. We also calculated the diameters of the occult liver metastases at the time of pancreatectomy on the assumption that the growth rates of liver metastasis were constant. Tumor doubling times of liver metastases in six patients were 34, 32, 318, 108, 78, and 27 d, respectively. In two of these patients, tumor doubling times, compared with cell doubling times of 51 and 52 h for PK-36 and PK-59 established from the same patients with carcinoma of the pancreas, were about 15 times as long as those of cultured cell lines. The calculated sizes of the occult liver metastases at the time of pancreatectomy in these six patients were 2.4, 0.14, 19.0, 8.2, 3.5, and 4.2 mm. In five of these six patients, the calculated sizes were in the range between 10 microns and 1 cm. These results indicated occult liver metastases had already existed in patients with carcinoma of the pancreas at the time of pancreatectomy and were too small to be detected by imaging technique. We cannot improve survival rates in carcinoma of the pancreas by surgical management alone. For further improvement in survival rate of patients with carcinoma of the pancreas to occur, effective adjuvant therapies to prevent liver metastases must complement surgical management.
通过测量肝转移灶的倍增时间,作者研究了胰腺癌患者在胰十二指肠切除时存在隐匿性肝转移的可能性。我们计算了6例壶腹周围癌患者胰十二指肠切除术后肝转移灶的肿瘤倍增时间,并与细胞倍增时间进行比较。我们还假设肝转移灶的生长速率恒定,计算了胰十二指肠切除时隐匿性肝转移灶的直径。6例患者肝转移灶的肿瘤倍增时间分别为34、32、318、108、78和27天。其中2例患者的肿瘤倍增时间,与从同一胰腺癌患者建立的PK - 36和PK - 59细胞系的细胞倍增时间(分别为51和52小时)相比,约为培养细胞系的15倍。这6例患者胰十二指肠切除时隐匿性肝转移灶的计算大小分别为2.4、0.14、19.0、8.2、3.5和4.2毫米。在这6例患者中的5例中,计算大小在10微米至1厘米之间。这些结果表明,胰腺癌患者在胰十二指肠切除时已经存在隐匿性肝转移,且转移灶太小,无法通过影像学技术检测到。仅通过手术治疗无法提高胰腺癌患者的生存率。为了进一步提高胰腺癌患者的生存率,必须采用有效的辅助治疗来预防肝转移,以补充手术治疗。